Global Childhood Cancer Burden: Addressing Inequities in Care

When we read a headline about global health statistics, This proves easy to view the numbers as distant, abstract data points. But for those of us living in Memphis, Tennessee, the global fight against pediatric cancer isn’t just a headline—it’s a daily reality. This city serves as the heartbeat of international pediatric oncology, primarily because it is home to St. Jude Children’s Research Hospital. The latest findings from the Global Burden of Disease (GBD) 2023 study, recently published in The Lancet, bring a stark reminder of why the work happening right here in our backyard is so critical to the rest of the world.

The Global Landscape of Pediatric Cancer

The data released in April 2026 paints a complex picture of progress and persisting inequality. According to the GBD 2023 study, childhood cancer remains the eighth-leading cause of childhood death globally. In a sobering comparison, it now causes more deaths than measles, tuberculosis, and HIV/AIDS combined. In 2023 alone, the world saw approximately 377,000 new cases of childhood cancer and 144,000 deaths. While these numbers are staggering, there is a glimmer of hope: since 1990, global deaths from childhood cancer have decreased by 27%.

However, the “success” of these numbers is heavily skewed. The research, led by experts including Lisa Force, MD, MPH, from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine, highlights a devastating gap in care. While outcomes have improved significantly in high-income countries, those gains have not been shared equitably. The vast majority of the burden falls on low- and middle-income countries (LMICs), which accounted for 85% of new cases, 94% of deaths, and 94% of disability-adjusted life years (DALYs) in 2023.

Understanding the Burden and the “Index Cancers”

To understand how researchers measure this impact, we have to appear at DALYs. Disability-adjusted life years are a comprehensive metric that doesn’t just count deaths; they measure the total years of healthy life lost by combining years of premature death with years lived with disability. This provides a much clearer picture of the socio-economic toll on families and health systems.

The study identifies that the greatest global burden in 2023 came from leukemias, non-Hodgkin lymphoma, and brain or central nervous system cancers. Interestingly, nearly half of all childhood cancer deaths in 2023 were attributed to the six “WHO GICC index cancers.” These specific cancer types are used by the World Health Organization’s Global Initiative for Childhood Cancer (GICC) as a mechanism to monitor progress and strengthen health systems worldwide.

The Path to 60% Survival

Established in 2018, the WHO GICC has set a clear, ambitious target: increasing the survival rate of children with cancer globally to at least 60% by 2030. This goal isn’t just about the medicine itself, but about the entire “diagnosis and care continuum.” In many parts of the world, children die not because the cancer is untreatable, but because of delays in diagnosis and a lack of access to essential treatments.

This is where the influence of Memphis-based institutions becomes evident. Nickhill Bhakta, MD, MPH, the St. Jude Global disease burden and simulation director, emphasizes that outcomes are largely determined by resource availability. By focusing on addressing inequities and supporting comprehensive improvements in how cancer is detected and treated, the global community can move closer to the GICC targets. For families navigating these challenges, accessing local healthcare services that understand the complexities of pediatric oncology is the first step toward better outcomes.

The GICC has even launched a multilingual online Community of Practice portal. This tool allows focal points in ministries of health to share resources, organize training, and manage partnerships, effectively exporting the high standards of care seen in leading institutions to regions that need them most.

Navigating Pediatric Care in Memphis

Given my background in analyzing geo-specific health trends, it’s clear that while Memphis is a global hub for research, local families still need a roadmap to navigate the overwhelming nature of a pediatric cancer diagnosis. The transition from a global statistic to a personal battle requires a specific set of professional supports. If you or a loved one are navigating this journey in the Memphis area, Try to look for these three types of specialized professionals.

Pediatric Oncology Case Managers

These professionals act as the bridge between the medical team and the family. When searching for a case manager, look for those who specialize in “continuum of care.” They should be able to coordinate everything from initial diagnostic imaging to long-term follow-up care, ensuring that no step in the treatment plan is missed due to administrative hurdles.

Pediatric Palliative Care Specialists

Palliative care is often misunderstood as end-of-life care, but in pediatric oncology, it is about quality of life. Look for specialists who focus on symptom management and psychological support for the child and the siblings. The goal should be reducing suffering and improving the daily lived experience of the patient, aligning with the core goals of the WHO GICC.

Medical Social Workers for Pediatric Families

The financial and emotional toll of cancer is immense. Seek out social workers who have specific experience with pediatric cancer grants and family support networks. A qualified professional in this field should be well-versed in navigating insurance barriers and connecting families with housing or transportation assistance during extended treatment periods.

Ready to locate trusted professionals? Browse our complete directory of top-rated pediatric healthcare experts in the memphis area today.